Marine macroalga-associated heterotroph Bacillus velezensis as prospective therapeutic agent

Chakraborty, Kajal and Francis, Aneetta (2021) Marine macroalga-associated heterotroph Bacillus velezensis as prospective therapeutic agent. Archives of Microbiology.

[img] Text
Archives of Microbiology_2021_Kajal Chakraborty_Marine_macroalga-associated_heterotroph_Bacillus.pdf
Restricted to Registered users only

Download (5MB) | Request a copy | Please mail the copy request to cmfrilibrary@gmail.com
Official URL: https://link.springer.com/article/10.1007/s00203-0...
Related URLs:

    Abstract

    Marine macroalgae and their accompanying microbial flora were proved to be the reservoir of potential bioactive compounds with promising pharmacological applications. Heterotrophic bacteria concomitant with the marine algae were isolated and screened for their antibacterial potential against clinically recognized pathogens. The bacterial isolate with greater bioactive properties was identified as Bacillus velezensis MBTDLP1 (phylum Firmicutes), which was isolated from the marine macroalga Laurencia papillosa, by integrated morphological, biochemical and molecular characterization. B. velezensis showed promising antibacterial property against methicillin-resistant Staphylococcus aureus and Vibrio parahemolyticus with inhibition zone of 32–36 mm. Organic ethyl acetate extract of the isolate also displayed prospective antibacterial activity against the test pathogens (minimum inhibitory concentration 7.5–15 µg/mL), coupled with promising antioxidant (IC50 0.1–0.9 mg/mL against oxidants), anti-inflammatory (IC50 0.01 mg/mL against 5-lipoxygenase), and carbolytic enzyme attenuation properties (IC50 0.1–0.4 mg/mL in response to α-amylase and α-glucosidase). Significant anticancer potential against breast carcinoma (MCF-7) cells (IC50 0.03 mg/mL) coupled with lesser cytotoxicity to the normal fibroblast (3T3L) cells (IC50 0.14 mg/mL) were also recognized. The apoptosis assay could give reasonable outcome as the organic extract of B. velezensis induced apoptosis to 81% of the cancer cells while maintaining almost 60% viability in normal cells. The results put forward that B. velezensis MBTDLP1 could be used to isolate bioactive compounds with therapeutic potential and biomedical applications.

    Item Type: Article
    Uncontrolled Keywords: Bacillus velezensis; MBTDLP1; Macroalga-associated heterotrophic bacteria; Laurencia papillosa; Antibacterial; Anti-inflammatory; Anticancer
    Subjects: Biochemistry > Bioprospecting
    Biochemistry > Bioactive compounds
    Biochemistry
    Algae
    Divisions: CMFRI-Kochi > Marine Biotechnology
    Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology
    CMFRI-Kochi > Marine Biotechnology
    Subject Area > CMFRI-Kochi > Marine Biotechnology
    Depositing User: Arun Surendran
    Date Deposited: 11 Feb 2021 09:58
    Last Modified: 30 Aug 2021 05:44
    URI: http://eprints.cmfri.org.in/id/eprint/14899

    Actions (login required)

    View Item View Item